Pfizer and its German partner have asked U.S. regulators to clear their updated COVID-19 vaccine for children as young as 6 months of age, the companies announced on Dec. 5.
On Oct. 20 — the very same day the Centers for Disease Control and Prevention’s (CDC) crooked vaccine advisory committee members voted to add COVID-19 shots to the Child and Adolescent Immunization Schedule — Indonesia’s Ministry of Health took a bold step in a different direction: It banned the sale and prescription of pediatric cough syrups and other liquid medications, at least temporarily.
Cole said the vaccines are formulated for a strain of the virus that is extinct, but the spike protein in the injections is from the original Wuhan strain and is causing these health problems.
Two months after COVID-19 vaccines were rolled out to the U.S. public, a statistically significant vaccine safety signal for myocarditis in males ages 8 to 21 appeared in the Centers for Disease Control’s (CDC) Vaccine Adverse Event Reporting System (VAERS) — but CDC officials waited another three months before alerting the public, according to a new study.
The CDC's Advisory Committee on Immunization Practices unanimously approved the addition of COVID-19 vaccines to the routine immunization schedules for children, adolescents and adults at its meeting Thursday.
A CDC committee will convene this week and likely vote Thursday to deliver permanent legal indemnity to Pfizer and Moderna, through the process of adding the drug companies’ mRNA injections to the child and adolescent immunization schedules.
